stella
beta
A Study of BL-B01D1 and Almonertinib in Patients With Resectable EGFR+ Stage II-IIIB NSCLC — Stella
Home
/
Non-Small Cell Lung Cancer
/
View on ClinicalTrials.gov
Recruiting
Back to Non-Small Cell Lung Cancer trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
China
West China Hospital, Sichuan University, Chengdu, Sichuan